Drug class
Tyrosine Kinase 2 Inhibitor
Mechanism of action
Tyrosine Kinase 2 Inhibitors [MoA]
General use cases
- Parapsoriasis
- moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
- active psoriatic arthritis in adults
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
